143 related articles for article (PubMed ID: 12117691)
1. Relapse of rheumatoid arthritis after substitution of oral for parenteral administration of methotrexate.
Rozin A; Schapira D; Balbir-Gurman A; Braun-Moscovici Y; Markovits D; Militianu D; Nahir MA
Ann Rheum Dis; 2002 Aug; 61(8):756-7. PubMed ID: 12117691
[No Abstract] [Full Text] [Related]
2. [Against parenteral gold therapy in rheumatoid arthritis].
Kellner H
Dtsch Med Wochenschr; 2011 Aug; 136(33):1677. PubMed ID: 21833892
[No Abstract] [Full Text] [Related]
3. Subcutaneous methotrexate is well tolerated and superior to oral methotrexate in the treatment of rheumatoid arthritis.
Hameed B; Jones H
Int J Rheum Dis; 2010 Oct; 13(4):e83-4. PubMed ID: 21199461
[No Abstract] [Full Text] [Related]
4. [Why we recommend parenteral methotrexate for the treatment of rheumatoid arthritis: a response and overview of the literature].
Fiehn C;
Z Rheumatol; 2019 May; 78(4):385-387. PubMed ID: 30941504
[No Abstract] [Full Text] [Related]
5. [Long-term combination therapy of chronic polyarthritis: methotrexate and parenteral gold].
Krause D
Z Rheumatol; 1998 Feb; 57(1):37-40. PubMed ID: 9566106
[No Abstract] [Full Text] [Related]
6. Severe myelotoxicity in rheumatoid arthritis patients treated with oral methotrexate.
Rodriguez-Gomez M; Fernandez-Sueiro JL; Ulibarrena C; Lopez-Barros G; Willisch A; Fernandez-Dominguez L
Clin Exp Rheumatol; 2001; 19(3):353. PubMed ID: 11407096
[No Abstract] [Full Text] [Related]
7. Limitations of the study of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: comment on the article by Braun et al.
Raghu P; Grover PS; Kumar A
Arthritis Rheum; 2008 Jul; 58(7):2209; author reply 2209-10. PubMed ID: 18576338
[No Abstract] [Full Text] [Related]
8. Parenteral methotrexate for the treatment of rheumatoid arthritis.
Yazici Y; Bata Y
Bull Hosp Jt Dis (2013); 2013; 71 Suppl 1():46-8. PubMed ID: 24219041
[TBL] [Abstract][Full Text] [Related]
9. Therapy: oral or subcutaneous methotrexate for rheumatoid arthritis?
Alsaeedi S; Keystone EC
Nat Rev Rheumatol; 2014 Oct; 10(10):578-9. PubMed ID: 25090946
[No Abstract] [Full Text] [Related]
10. Subtherapeutic dosing of methotrexate in rheumatoid arthritis trials.
Parker CT; Mewshaw E; Dennis GJ
J Am Osteopath Assoc; 2004 Jan; 104(1):7-8. PubMed ID: 14992316
[No Abstract] [Full Text] [Related]
11. Oral methotrexate: the hazard of different tablet strengths.
Schott JM; Rigby SP; McNally JD; Keat A; Higgens CS
Rheumatology (Oxford); 1999 Apr; 38(4):382. PubMed ID: 10378725
[No Abstract] [Full Text] [Related]
12. Is parenteral methotrexate worth trying?
Osman A; Mulherin D
Ann Rheum Dis; 2001 Apr; 60(4):432. PubMed ID: 11284459
[No Abstract] [Full Text] [Related]
13. Oral Methotrexate in split dose weekly versus oral or parenteral Methotrexate once weekly in Rheumatoid Arthritis: a short-term study.
Dhaon P; Das SK; Srivastava R; Agarwal G; Asthana A
Int J Rheum Dis; 2018 May; 21(5):1010-1017. PubMed ID: 27455886
[TBL] [Abstract][Full Text] [Related]
14. [For parenteral gold therapy in rheumatoid arthritis].
Wassenberg S
Dtsch Med Wochenschr; 2011 Aug; 136(33):1676. PubMed ID: 21833891
[No Abstract] [Full Text] [Related]
15. [Methotrexate: advantages of subcutaneous administration].
Krüger K
Z Rheumatol; 2008 Jul; 67(4):332-3. PubMed ID: 18443809
[No Abstract] [Full Text] [Related]
16. Methotrexate in rheumatoid arthritis: optimizing therapy among different formulations. Current and emerging paradigms.
Cipriani P; Ruscitti P; Carubbi F; Liakouli V; Giacomelli R
Clin Ther; 2014 Mar; 36(3):427-35. PubMed ID: 24612941
[TBL] [Abstract][Full Text] [Related]
17. Bioavailability of higher dose MTX comparing oral and subcutaneous administration in patients with RA.
Rau R
J Rheumatol; 2005 Jul; 32(7):1412; author reply 1412-3. PubMed ID: 15996092
[No Abstract] [Full Text] [Related]
18. Parenteral methotrexate should be given before biological therapy.
Griffin AJ; Erkeller-Yuksel F
Rheumatology (Oxford); 2004 May; 43(5):678; author reply 678-9. PubMed ID: 15103040
[No Abstract] [Full Text] [Related]
19. When should we use parenteral methotrexate?
Mainman H; McClaren E; Heycock C; Saravanan V; Hamilton J; Kelly C
Clin Rheumatol; 2010 Oct; 29(10):1093-8. PubMed ID: 20544244
[TBL] [Abstract][Full Text] [Related]
20. Optimizing methotrexate therapy in rheumatoid arthritis: a systematic literature review.
Mouterde G; Baillet A; Gaujoux-Viala C; Cantagrel A; Wendling D; Le Loët X; Schaeverbeke T
Joint Bone Spine; 2011 Dec; 78(6):587-92. PubMed ID: 21444233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
